| Vaccines |
Hepatitis A Vaccine (Human Diploid Cell), Inactivated
| Dosage form |
| 0.5ml/vial & prefilled syringe for children 1.0ml/vial & prefilled syringe for adults |
| Inoculations process |
| 1-15 years old for children, Above 16 years old for adults 0, 6 month |
Recombinant Hepatitis B Vaccine (Saccharomyces cerevisiae)
| Dosage form |
| 0.5ml/vial for children 1ml/vial for adults |
| Inoculations process |
| 0, 1, 6 months for children |
Diphtheria, Tetanus, Acellular Pertussis and Haemophilus Influenzae Type b Combined Vaccine
| Dosage form |
| 0.5ml/vial DTaP 0.5ml/vial Hib lyophilized powder |
| Inoculations process |
| 3, 4, 5 months + 18 month |
Group ACY W135 Meningococcal Polysaccharide Vaccine
| Dosage form |
| 0.5ml/vial |
| Inoculations process |
| Above 2 years old and adults |
Measles and Rubella Combined Vaccine , Live
| Dosage form |
| 0.5ml/vial |
| Inoculations process |
| Above 8 months |
Influenza Vaccine (Split Virion), Inactivated
| Dosage form |
| 0.25ml/vial for children 0.5ml/vial for adults |
| Inoculations process |
| 6-36 months for children above 36 months for adults |
Enterovirus Type 71 Vaccine (Vero Cell), Inactived
| Dosage form |
| 0.5ml/vial 0.5ml/prefilled syringe |
| Inoculations process |
| 6 months to 5 years old |
Rabies Vaccine for Human Use (Human Diploid Cell), Freeze-dried
| Dosage form |
| 1ml/vial |
| Inoculations process |
| 0, 3, 7, 14, 28 days after bitted |
Varicella Vaccine, Live
| Dosage form |
| 0.5ml/vial 0.5ml/prefilled syringe |
| Inoculations process |
| 1 year old to 12 years old |
Inactivated Poliomyelitis Vaccine , Sabin Strains
| Dosage form |
| 0.5ml/vial |
| Inoculations process |
| 2, 3, 4 months + 18 months |
13-Valent Pneumococcal Conjugate Vaccine (PCV-13)
| Dosage form |
| 0.5ml/prefilled syringe |
| Inoculations process |
| 6 weeks to 5 years old and above 50 years old |
23-Valent Pneumococcal Polysaccharide Vaccine (PPV-23)
| Dosage form |
| 0.5ml/vial 0.5ml/prefilled syringe |
| Inoculations process |
| Above 2 years old |
Bivalent Human Papillomavirus Vaccine (HPV-2)
| Dosage form |
| 0.5ml/vial 0.5ml/prefilled syringe |
| Inoculations process |
| 0, 1, and 6 months |
Monoclonal Antibody
| Generic | Originator | Brand name | Target | Indication |
|---|---|---|---|---|
| Adalimumab | Abbott | Humira | TNF | RA, SA |
| Ado-Trastuzumab | Roche | Kadcyla | HER-2 | Oncology |
| Aflibercept | Sanofi | Eylea | VEGF | wAMD, RVO, DME, DR |
| Bevacizumab | Roche | Avastin | VEGF | Oncology |
| Cetuximab | Imclone/BMS | Erbitux | EGFR | Oncology |
| Densosumab | Amgen | Prolia | PANKL | Oncology |
| Evolocumab | Amgen | Repatha | PCSK-9 | High Cholestrol |
| Infliximab | Johnson&Johnson | Remicade | TNF | RA, IBD |
| Ipilimumab | BMS | Yervoy | CTLA-4 | Oncology |
| Nivolumab | BMS | Opdivo | PD-1 | Oncology |
| Omalizumab | Novartis | Xolair | IgE | Asthma |
| Pembrolizumab | MSD | Keytruda | PD-1 | Oncology |
| Pertuzumab | Roche | Perjeta | HER-2 | Oncology |
| Rituximab | Roche | Mabthera | CD20 | Oncology |
| Tocilizumab | Roche | Actemra | IL-6 | RA |
| Trastuzumab | Roche | Herceptin | HER-2 | Oncology |
Peptides
| Product Name | CAS No. | Stardand | Documentation |
|---|---|---|---|
| Albiglutide | 782500-75-8 | In-house | TP |
| Argireline | 616204-22-9 | In-house | TP |
| Atosiban | 90779-69-4 | In-house | TP |
| Bivalirudin | 128270-60-0 | In-house | DMF |
| Carbetocin | 37025-55-1 | In-house | DMF |
| Caspofungin Acetate | 179463-17-3 | In-house | DMF |
| Gonadorelin Acetate | 33515-09-2 | USP,BP,EP | TP |
| Degarelix acetate | 214766-78-6 | In-house | DMF |
| Deslorelin | 57773-65-6 | In-house | TP |
| Desmopressin | 16679-58-6 | USP,BP,EP | GMP,DMF |
| Dulaglutide | 923950-08-7 | In-house | TP |
| Eptifibatide | 148031-34-9 | In-house | DMF |
| Exenatide | 141732-76-5 | In-house | TP |
| Glatiramer Acetate | 147245-92-9 | In-house | TP |
| Glucagon | 16941-32-5 | USP,BP,EP | GMP |
| Goserelin Acetate | 145781-92-6 | USP,BP,EP | DMF |
| Leuprorelin | 53714-56-0 | BP,EP | TP |
| Linaclotide | 851199-59-2 | In-house | DMF |
| Liraglutide | 204656-20-2 | In-house | DMF |
| Nesiritide | 124584-08-3 | In-house | DMF |
| Octreotide Acetate | 83150-76-9 | CP,USP,BP,EP | GMP |
| Oxytocin | 50-56-6 | EP,USP | CEP,GMP |
| Pramlintide | 151126-32-8 | In-house | GMP |
| Protirelin | 24305-27-9 | BP,EP | GMP |
| Salmon Calcitonin | 47931-85-1 | CP,USP,BP,EP | GMP |
| Somatostatin | 38916-34-6 | CP,BP,EP | GMP |
| Terlipressin | 14636-12-5 | CP | GMP,EDMF |
| Thymopentin | 69558-55-0 | CP | GMP |
| Thymosin α1 | 62304-98-7 | CP | GMP |
| Triptorelin | 57773-63-4 | In-house | GMP |
| Vasopressin | 113-79-1 | USP,In-house | TP |
Others
| Product Name | Specification |
| Erythropoietin | 2000IU/ml, 3000IU/ml, 4000IU/ml, 6000IU/ml, 10000IU/ml |
| Filgrastim | 75mcg/0.5ml 150mcg/0.5ml 300mcg/ml |
| Human Albumin 20% | 20g/vial (100ml) 12.5g/vial (62.5ml) 10g/vial (50ml) 5g/vial (25ml) 2g/vial (10ml) |
| Human Immunoglobulin for Intravenous Injection (IVIG) 5% | 10g/vial (200ml) 5g/vial (100ml) 2.5g/vial (50ml) 1.25g/vial (25ml) 1g/vial (20ml) 0.5g/vial (10ml) |
| Human Hepatitis B Immunoglobulin | 500IU/vial (5ml) 250IU/vial (2.5ml) |
| Human Tetanus Immunoglobulin | 500IU/vial (5ml) 250IU/vial (2.5ml) |
| Human Rabies Immunoglobulin | 500IU/vial (5ml) 200IU/vial (2ml) 100IU/vial (1ml) |
| Insulin Aspart | USP,BP,EP |
| Insulin Glargine | USP,EP |
| Insulin Degludec | In-house |
| Recombinant Insulin Human | USP,EP,CP 1500IU/vial |
| Tetanus Antitoxin | 3000IU/vial 5000IU/vial 10000IU/vial |